[HTML][HTML] Do diet and dietary supplements mitigate clinical outcomes in COVID-19?

B Singh, E Eshaghian, J Chuang, M Covasa - Nutrients, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) has caused a pandemic and upheaval that
health authorities and citizens around the globe are still grappling with to this day. While …

Theranostic efficiency of biosurfactants against COVID-19 and similar viruses-A review

MK Sarangi, S Padhi, LD Patel, G Rath… - Journal of Drug Delivery …, 2022 - Elsevier
The world has witnessed an extreme vulnerability of a pandemic during 2020; originated
from China. The coronavirus disease 2019 (COVID-19) is infecting and beginning deaths in …

[PDF][PDF] Macroalgae bioactive compounds for the potential antiviral of SARS-CoV-2: An in silico study

H Padmi, VD Kharisma, ANM Ansori… - J Pure Appl …, 2022 - eprints.unram.ac.id
Abstract Coronavirus disease (COVID-19), which was due to novel coronavirus was
detected in December 2019 in Wuhan, China for the first time and spread rapidly became a …

Detoxifying SARS-CoV-2 antiviral drugs from model and real wastewaters by industrial waste-derived multiphase photocatalysts

M Hojamberdiev, B Czech, A Wasilewska… - Journal of hazardous …, 2022 - Elsevier
The use of antiviral drugs has surged as a result of the COVID-19 pandemic, resulting in
higher concentrations of these pharmaceuticals in wastewater. The degradation efficiency of …

Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: a method comparison …

T Mueller - Clinica Chimica Acta, 2021 - Elsevier
Background We compared two serological assays from Roche Diagnostics in individuals
with and without COVID-19 vaccination, namely the Elecsys Anti-SARS-CoV-2 assay …

Revealing the toxicity of lopinavir-and ritonavir-containing water and wastewater treated by photo-induced processes to Danio rerio and Allivibrio fischeri

B Czech, A Krzyszczak… - Science of the Total …, 2022 - Elsevier
Abstract In coronavirus disease 2019 (COVID-19), among many protocols, lopinavir and
ritonavir in individual or combined forms with other drugs have been used, causing an …

Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo

S Andreu, C von Kobbe, P Delgado, I Ripa… - Frontiers in …, 2023 - frontiersin.org
The emergent human coronavirus SARS-CoV-2 and its resistance to current drugs makes
the need for new potent treatments for COVID-19 patients strongly necessary. Dextran …

Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19

SC Karunarathna, W Lu, N Patabedige… - New Zealand Journal …, 2024 - Taylor & Francis
The global COVID-19 pandemic, caused by SARS-CoV-2, has created an urgent need for
novel antiviral agents, as it has led to a devastating loss of lives worldwide. In response …

mRNA-based nanomedicine: A new strategy for treating infectious diseases and beyond

S Prakash - European Journal of Drug Metabolism and …, 2023 - Springer
Messenger RNA (mRNA) has emerged as a new therapeutic agent for the prevention and
treatment of a wide range of diseases. The recent achievement of the two lipid nanoparticle …

Nanotechnology and COVID-19: quo vadis?

JL Tavares, IDL Cavalcanti… - Journal of Nanoparticle …, 2022 - Springer
The pandemic COVID-19 has worried everyone due to the high mortality rate and the high
number of people hospitalized with severe acute respiratory syndrome caused by SARS …